Mr Ian Boostrom

2025

• Sands, K. et al. 2025. Acquisition of Escherichia coli carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in Niger. Nature Communications 16(1), article number: 6751. (10.1038/s41467-025-61718-w)

2024

• Nieto-Rosado, M. et al. 2024. Colonisation of hospital surfaces from low- and middle-income countries by extended spectrum β-lactamase- and carbapenemase-producing bacteria. Nature Communications 15, article number: 2758. (10.1038/s41467-024-46684-z)
• Portal, E. A. R. et al. 2024. Characterisation of colistin resistance in Gram-negative microbiota of pregnant women and neonates in Nigeria. Nature Communications 15(1), article number: 2302. (10.1038/s41467-024-45673-6)

2023

• Farzana, R. et al. 2023. Genomic insights into the mechanism of carbapenem resistance dissemination in Enterobacterales from a tertiary public heath setting in South Asia. Clinical Infectious Diseases 76(1), pp. 119-133. (10.1093/cid/ciac287)

2022

• Carvalho, M. J. et al. 2022. Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countries. Nature Microbiology 7, pp. 1337-1347. (10.1038/s41564-022-01184-y)
• Acolatse, J. E. E. et al. 2022. Environmental surveillance of ESBL and carbapenemase-producing gram-negative bacteria in a Ghanaian Tertiary Hospital. Antimicrobial Resistance and Infection Control 11(1), article number: 49. (10.1186/s13756-022-01090-2)
• Boostrom, I., Portal, E. A. R., Spiller, O. B., Walsh, T. R. and Sands, K. 2022. Comparing long-read assemblers to explore the potential of a sustainable low-cost, low-infrastructure approach to sequence antimicrobial resistant bacteria with Oxford nanopore sequencing. Frontiers in Microbiology 13, article number: 796465. (10.3389/fmicb.2022.796465)

2021

• Boostrom, I. et al. 2021. Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial. Journal of Antimicrobial Chemotherapy 76(12), pp. 3175-3182. (10.1093/jac/dkab320)
• Sharratt, M. et al. 2021. Defining fluoroquinolone resistance-mediating mutations from non-resistance polymorphisms in Mycoplasma hominis Topoisomerases. Antibiotics 10(11), article number: 1379. (10.3390/antibiotics10111379)
• Spiller-Boulter, O., Paukner, S., Boostrom, I., Sands, K., Portal, E. A. R. and Spiller, O. B. 2021. Determination of in vitro antimicrobial susceptibility for Lefamulin (Pleuromutilin) for Ureaplasma Spp. and Mycoplasma hominis. Antibiotics 10(11), article number: 1370. (10.3390/antibiotics10111370)

2020

• Pasqualetto, G. et al. 2020. Computational studies towards the identification of novel rhodopsin-binding compounds as chemical chaperones for misfolded opsins. Molecules 25(21), article number: 4904. (10.3390/molecules25214904)
• Farzana, R. et al. 2020. Molecular and epidemiological analysis of a Burkholderia cepacia sepsis outbreak from a tertiary care hospital in Bangladesh. PLoS Neglected Tropical Diseases 14(4), article number: e0008200. (10.1371/journal.pntd.0008200)

2019

• Farzana, R. et al. 2019. Emergence of mcr-1 mediated colistin resistant Escherichia coli from a hospitalized patient in Bangladesh. Journal of Infection in Developing Countries 13(8), pp. 773-776. (10.3855/jidc.11541)